- MAIA Biotechnology Announces Share Purchase by Director Adelina Louie in Private Placement
- MAIA Biotechnology Announces Share Purchase by Director Stan Smith, Ph.D. in Private Placement
- MAIA Biotechnology Announces $1.00 Million Private Placement
- MAIA Biotechnology to Present at Two Investor Conferences in April 2024
- MAIA Biotechnology Announces Share Purchases by Directors Cristian Luput and Ramiro Guerrero
- MAIA Biotechnology Announces $1.33 Million Private Placement
- MAIA Biotechnology Announces Share Purchase by Director Stan Smith, PhD in a $2.9 Million Private Placement
- MAIA Biotechnology Welcomes Prominent Medical Oncology Scientist Dr. Saadettin Kilickap to its Scientific Advisory Board
- MAIA Biotechnology to Participate in the 36th Annual ROTH Conference
- MAIA Biotechnology and Nationwide Children’s Hospital Announce Presentation of THIO’s Potency in Pediatric Brain Tumors at American Association of Cancer Research Annual Meeting
More ▼
Key statistics
On Friday, Maia Biotechnology Inc (MAIA:ASQ) closed at 3.08, -14.21% below its 52-week high of 3.59, set on Apr 30, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.85 |
---|---|
High | 3.18 |
Low | 2.70 |
Bid | 3.06 |
Offer | 3.14 |
Previous close | 2.89 |
Average volume | 412.14k |
---|---|
Shares outstanding | 20.91m |
Free float | 17.01m |
P/E (TTM) | -- |
Market cap | 60.43m USD |
EPS (TTM) | -1.49 USD |
Data delayed at least 15 minutes, as of May 10 2024 23:30 BST.
More ▼